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Cyp46a1Oxysterols are oxidised forms of cholesterol or its precursors. In this study we utilised the cholesterol 24-
hydroxylase knockout mouse (Cyp46a1/) to study the sterol and oxysterol content of brain. Despite a
great reduction in the abundance of 24S-hydroxycholesterol, the dominant metabolite of cholesterol in
wild type brain, no other cholesterol metabolite was found to quantitatively replace this oxysterol in
the Cyp46a1/ mouse. Only minor amounts of other side-chain oxysterols including 22R-, 24R-, 25-
and (25R),26-hydroxycholesterols were detected. In line with earlier studies, levels of cholesterol were
similar in Cyp46a1/ and wild type animals. However, the level of the cholesterol precursor, desoms-
terol, and its parallel metabolite formed via a shut of the mevalonate pathway, 24S,25-epoxycholesterol,
were reduced in the Cyp46a1/mouse. The reduction in abundance of 24S,25-epoxycholesterol is inter-
esting in light of a recent report indicating that this oxysterol promotes dopaminergic neurogenesis.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY license.1. Introduction
Hydroxylation of cholesterol to give 24S-hydroxycholesterol, in
a reaction catalysed by the enzyme cytochrome P450 (CYP) 46A1,
represents the major route for removal of cholesterol from the
brain of mouse and man [1,2]. 24S-Hydroxycholesterol can cross
the blood brain barrier and is transported in the blood stream to
the liver where it is metabolised to bile acids [3]. The mouse en-
zyme, Cyp46a1, is expressed in neurons in brain and at low levels
in liver [4]. The human enzyme, CYP46A1, is expressed in neurons
in normal human brain and also in glial cells in Alzheimer’s disease
patients [5]. Earlier studies of the Cyp46a1/ mouse revealed a
reduction in de novo cholesterol synthesis in brain and indicated
that brain cholesterol homeostasis is maintained via reduced
biosynthesis rather than via up-regulation of an alternativemetabolising enzyme [6]. The Cyp46a1/ mouse shows impaired
learning and memory, and further studies revealed that this is a
consequence of a reduced ﬂow of metabolites through the choles-
terol biosynthetic pathway (also known as the mevalonate path-
way) [7,8].
Oxysterols have been shown to be more than transport forms of
cholesterol, and there is mounting evidence that they represent
important signalling molecules. They may exert biological activity
as ligands to INSIG (insulin induced gene) and thereby modulate
cholesterol biosynthesis by retaining SCAP (SREBP cleavage-acti-
vating protein) and SREBP-2 (sterol regulatory-element binding
protein 2) within the endoplasmic reticulum, thus attenuating
the formation of mature SREBP-2, the master transcription factor
of the cholesterol biosynthetic pathway [9,10]. Oxysterols also
act as ligands to nuclear receptors. Those with a side-chain
hydroxy-, oxo-, epoxy- or carboxylate group can act as ligands
to the liver x receptors (Lxr) which are expressed in brain
[11,12]. Recent reports indicate that activation of Lxr by
oxysterols can induce neurogenesis of dopaminergic neurons
[13,14]. In normal rodent brain the oxysterol proﬁle is completely
dominated by 24S-hydroxycholesterol [15,16], obscuring the
possible presence of alternative cholesterol metabolites. The
Cyp46a1/ mouse thus provides an excellent opportunity to
proﬁle low-level oxysterols, with potential biological activity,
without being obscured by the overwhelming background of
24S-hydroxycholesterol.
A. Meljon et al. / Biochemical and Biophysical Research Communications 446 (2014) 768–774 7692. Methods
2.1. Reagents and standards
Sterol standards were obtained from Avanti Polar Lipids
(Alabaster, Alabama, USA). Cholesterol oxidase from Streptomyces
sp. was from Sigma–Aldrich (Dorset, UK). Girard P (GP) reagent
[1-(carboxymethyl)pyridinium chloride hydrazide] was from TCI
Europe (Oxford, UK). Reversed phase (RP) solid phase extraction
(SPE) cartridges, Certiﬁed Sep-Pak C18, 200 mg, were from Waters
Inc (Elstree, UK). Solvents and other reagents were from Fisher-Sci-
entiﬁc (Loughborough, UK), VWR (Lutterworth, UK) and Sigma–
Aldrich.
A stock solution of deuterated 24R/S-hydroxycholesterol stan-
dard was prepared by dissolving 1 mg of 24R/S-[26,26,26,27,27,
27-2H6]hydroxycholesterol in propan-2-ol (10 mL). Ten lL of this
stock solution was diluted with 990 lL of ethanol to make a work-
ing solution of 1 ng/lL. A solution of deuterated cholesterol was
prepared by dissolving 10 mg of [25,26,26,26,27,27,27-2H7]choles-
terol in 10 mL of propan-2-ol to make a solution of 1 lg/lL.
2.2. Extraction of sterols and oxysterols from brain
Brain extracts were a generous gift from David Russell, Univer-
sity of Texas Southwestern Medical Center at Dallas. Lipids were
extracted from brains of four 15 week old female mice, two Cy-
p46a1/ animals and two wild type (wt, Cyp46a1+/+) controls
[6]. Brain tissue (0.4–0.5 g, wet weight) was homogenised in PBS
(1.2 mL) and CHCl3:CH3OH (1:2, v/v, 6 mL) added. After further
homogenisation the mixture was centrifuged (1360g) for 10 min
at 4 C. The supernatant was decanted to a fresh tube and CHCl3
(2 mL) and PBS (2 mL) were added. Following further centrifuga-
tion the organic phase was removed and solvents evaporatedcholesterol ox
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Fig. 1. Charge-tagging of oxysterols. The 3b-hydroxy group is oxidised with cholesterol
hydrazone. MS2 of the [M]+ ion results in a major [M-79]+ fragment ion due to loss of the
informative fragment ions, see Supplementary Fig. S1. Oxysterols with a natural 3-oxo g
tagging procedure in the absence of cholesterol oxidase.[17]. Lipid extracts each corresponding to 100 mg of brain wet
weight were dissolved in 1.05 mL of ethanol containing 50 ng of
24R/S-[2H6]hydroxycholesterol and 50 lg of [2H7]cholesterol and
ultrasonicated for 15 min at room temperature. To the mixture
0.45 mL of water was added and the extract was sonicated for an-
other 15 min. The mixture was centrifuged (14,000g, 4 C, 60 min)
and the supernatant was collected. The residue was extracted a
second time and the supernatants combined.
Next, oxysterols were separated from cholesterol in order to
prevent contamination of the endogenous oxysterol content by
cholesterol autoxidation products generated during subsequent
sample preparation. A Certiﬁed Sep-Pak C18 column (200 mg)
was washed with 4 mL of ethanol then conditioned with 6 mL of
70% ethanol. The brain extract, now in 70% ethanol (3 mL), was ap-
plied to the column and allowed to ﬂow at a rate of 0.25 mL/min.
Flow was enhanced using a vacuum manifold (Vacuum Processing
Station, Agilent, Waghaeusel – Wiesental, Germany). The ﬂow-
through was combined with a wash of 4 mL of 70% ethanol giving
fraction SPE1-FR1 (7 mL 70% ethanol). Oxysterols elute in this frac-
tion [18,19]. A second wash with another 4 mL of 70% ethanol gen-
erated fraction SPE1-FR2. Cholesterol was eluted from the Sep-Pak
column with 2 mL of ethanol (SPE1-FR3). A ﬁnal column stripping
with a 2 mL aliquot of ethanol eluted more hydrophobic sterols.
(SPE1-FR4). Each fraction from the column (SPE1-FR1?4) was di-
vided into two equal portions giving e.g. SPE1-FR1A, SPE1-FR1B
etc. All fractions were dried in a vacuum concentrator and reconsti-
tuted in 100 lL of propan-2-ol.
2.3. Charge-tagging
3b-Hydroxy groups in the oxysterols/sterols were ﬁrst
converted to 3-oxo groups using cholesterol oxidase from Strepto-
myces sp. (Fig. 1) [20]. A solution of 50 mM phosphate buffer (1 mL,idase
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oxidase to a 3-oxo group which is then derivatised with GP hydrazine to give a GP-
pyridine ring. Further fragmentation of the [M-79]+ ion by MS3 leads to structurally
roup are differentiated from those oxidised to contain one by repeating the charge-
770 A. Meljon et al. / Biochemical and Biophysical Research Communications 446 (2014) 768–774KH2PO4, pH 7) containing 3.0 lL of cholesterol oxidase (2 mg/mL in
H2O, 44 units/mg of protein) was added to the A fractions (i.e.
SPE1-FR1A?4A). In a similar manner, 50 mM phosphate buffer
(1 mL, KH2PO4, pH 7) but without cholesterol oxidase was added
to the B fractions (SPE1-FR1B?4B). The mixtures were incubated
at 37 C for 1 h, and the reaction was terminated with 2 mL of
methanol. Oxysterols/sterols possessing an oxo group either natu-
rally or as a result of treatment with cholesterol oxidase were der-
ivatised with GP reagent [18,19]. One hundred and ﬁfty lL of
glacial acetic acid and 150 mg of GP hydrazine were added to each
of the fractions above, now in 3 mL of 70% methanol. The mixture
was incubated at room temperature overnight in the dark. The der-
ivatised oxysterols/sterols were separated from excess GP reagent
using a recycling method on new C18 SPE columns [18,19]. Deriva-
tised oxysterols were ultimately eluted in 2 mL of methanol, while
derivatised cholesterol eluted in 3 mL of methanol.
2.4. LC–ESI–MS(MSn)
The liquid chromatography–electrospray ionisation–mass spec-
trometry (LC–ESI–MS) system utilised in this study consisted of an
LTQ-Orbitrap XL (Thermo Scientiﬁc, Hemel Hempstead, UK)
equipped with an ESI probe and a Dionex Ultimate 3000 LC system
(Dionex, Camberley, Surrey, UK). Chromatographic separation was
achieved using a Hypersil Gold RP column (50  2.1 mm, 1.9 lm;
Thermo Scientiﬁc) at room temperature. Injections (5–20 lL) of
oxysterols/sterols were made in 60% methanol, 0.1% formic acid.
Mobile phase A consisted of 0.1% formic acid in 33.3% methanol,Table 1
Oxysterols identiﬁed in Cyp46a1+/+ and Cyp46a/ mouse brain.
Cmpd Structure after treatment with
cholesterol oxidase
Originating structure systematic name (c
name)
1 24S,25-Epoxycholest-4-en-3-
one
3b-Hydroxycholest-5-en-24S,25-epoxide
epoxycholesterol)
2 Cholest-4-ene-3,24-dione 3b-Hydroxycholest-5-ene-3,24-dione (24
oxocholesterol)a
3 24,25-Dihydroxycholest-4-
en-3-one
Cholest-5-en-3b,24,25-triol (24,25-
dihydroxycholesterol)b
4 24-Hydroxy-25-methoxy-
cholest-4-en-3-one
3b,24-Dihydroxycholest-5-ene-25-metho
5 Sum Total 3b-hydroxycholest-5-en-24S,25-ep
(24S,25-epoxycholesterol)d
6 22R-Hydroxycholest-4-en-3-one Cholest-5-ene-3b,22R-diol (22R-
hydroxycholesterol)
7 24S-Hydroxycholest-4-en-3-one Cholest-5-ene-3b,24S-diol (24S-
hydroxycholesterol)
8 24R-Hydroxycholest-4-en-3-one Cholest-5-ene-3b,24R-diol (24R-
Hydroxycholesterol)e
9 25-Hydroxycholest-4-en-3-one Cholest-5-ene-3b,25-diol (25-hydroxycho
10 26-Hydroxycholest-(25R)-4-en-
3-one
Cholest-(25R)-5-ene-3b,26-diol ((25R),26
hydroxycholesterol or 27-hydroxycholest
11 x-Hydroxycholest-4-en-3-one Cholest-5-en-3b,x-diol (x-hydroxycholest
12 7b-Hydroxycholest-4-en-3-one Cholest-5-ene-3b,7b-diol (7b-Hydroxycho
13 7a-Hydroxycholest-4-en-3-one Cholest-5-ene-3b,7a-diol (7a-hydroxycho
14 6-Hydroxycholest-4-en-3-one Cholest-5-ene-3b,6-diol (6-hydroxychole
15 20R,22R-Dihydroxycholest-4-
en-3-one
Cholest-5-en-3b,20R,22R-triol (20R,22R-
dihydroxycholesterol)
Oxysterols identiﬁed by retention time, exact mass, MSn spectra and comparison to a
[25,25,25,26,26,26-2H6]hydroxycholesterol internal standard. Mean concentration ± sta
duplicate.
a Isomerisation product of 24S,25-epoxide during derivatisation.
b Hydrolysis product of 24S,25-epoxide during derivatisation.
c Methanolysis product of 24S,25-epoxide during derivatisation. MSn suggests a 24-h
d Total 24S,25-epoxycholesterol, sum of cmpds 1–4.
e Quantiﬁcation of 24R-hydroxycholesterol and (25R),26-hydroxycholesterol is approx
f Systematic nomenclature deﬁnes the hydroxy group on the terminal carbon of the ste
carbon-25. However, on account of the enzyme Cyp27 catalysing this hydroxylation, th
g The site of hydroxylation is probably on the side chain at a primary or secondary ca
h May be an autoxidation product of cholesterol.
i Can be formed enzymatically or as an autoxidation product of cholesterol.
j Dehydration product of cholest-5-ene-3b,5,6-triol a hydrolysis product of 5,6-epoxy16.7% acetonitrile. Mobile phase B consisted of 0.1% formic acid
in 63.3% methanol 31.7% acetonitrile. Gradient elution was per-
formed as described in [18].
The LC–ESI–MS and LC–ESI–MSn methods were essentially as
described earlier [18]. The LTQ-Orbitrap XL was operated utilising
three scan events. First a Fourier transform (FT) MS scan was per-
formed in the Orbitrap over the m/z range 400–605 at 30,000 res-
olution (full width at half-maximum height deﬁnition), in the
second event the MS3 transition e.g. (534.4?455.4?) was moni-
tored using collision energies of 30 and 35 for MS2 and MS3,
respectively. In the third event another MS3 transition e.g.
(540.4?461.4?) was monitored in a similar manner (e.g. to
accommodate the 24R/S-[2H6]hydroxycholesterol internal stan-
dard). The MS3 transitions utilised in the analysis of brain samples
are given in Table 1. Oxysterols were quantiﬁed with 24R/S-[2H6-
]hydroxycholesterol as internal standard, while cholesterol and
other hydrophobic sterols were quantiﬁed with [2H7]cholesterol
as internal standard. Previous studies by Karu et al. have shown
that GP-tagged 3-oxo-4-ene oxysterols (derived by oxidation with
cholesterol oxidase from 3b-hydroxy-5-ene precursors) give equiv-
alent response factors in LC–ESI–MS [15].
3. Results
3.1. WT (Cyp46a1+/+) mice
The reconstructed ion chromatogram (RIC) ofm/z 534.4054 cor-
responding to the [M]+ ion of GP-tagged monohydroxycholesterolsommon [M]+ of GP derivative and
MS3 transition (m/z)
Rt/
min
Cyp46a1+/+
(ng/mg)
Cyp46a1/
(ng/mg)
(24S,25- 532.3898 532.4?453.3? 6.94 0.03 ± 0.00 0.003 ± 0.001
- 532.3898 532.4?453.3? 7.92 0.34 ± 0.02 0.005 ± 0.003
550.4003 550.4?471.4? 4.09/
4.82
0.16 ± 0.00 0.078 ± 0.029
xidec 564.4160 564.4?485.4? 6.26/
6.74
0.12 ± 0.00 0.037 ± 0.019
oxide 0.64 ± 0.02 0.124 ± 0.044
534.4054 534.4?455.4? 6.23 ND <0.005
534.4054 534.4?455.4? 7.47/
7.78
27.91 ± 0.73 0.017 ± 0.003
534.4054 534.4?455.4? 7.89/
8.25
Approx 6 0.05 Appox 0.15
lesterol) 534.4054 534.4?455.4? 7.63 60.05 0.050 ± 0.009
-
erol)e,f
534.4054 534.4?455.4? 8.04 Approx 0.3 Approx 0.15
erol)g 534.4054 534.4?455.4? 8.92 60.05 0.030 ± 0.035
lesterol)h 534.4054 534.4?455.4? 9.64 60.05 0.183 ± 0.243
lesterol)i 534.4054 534.4?455.4? 10.18 60.05 0.040 ± 0.053
sterol)j 534.4054 534.4?455.4? 10.56 ND 0.053 ± 0.069
550.4003 550.4?471.4? 4.51 60.05 0.030 ± 0.002
uthentic standards. Quantiﬁcation was made against the internal standard 24R/S-
ndard deviation for two Cyp46a1+/+ and two Cyp46a1/ animals analysed in
ydroxy-25-methoxy structure.
imate as the derivatives are only resolved from one another in MRM chromatograms.
rol side chain to be attached to carbon-26 when R stereo chemistry is introduced at
e common name for the hydroxycholesterol is 27-hydroxycholesterol.
rbon.
cholesterol, an autoxidation product of cholesterol.
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Fig. 2. Chromatographic separation of charge-tagged monohydroxycholesterols. RIC for m/z 534.4054 corresponding to the [M]+ ion of monohydroxycholesterols (HC) from
(A) Cyp46a1+/+, and (B) Cyp46a1/, mouse brain. (C) MRM of the transition 534?455?353 from Cyp46a1/mouse brain. (D) MRM of the transition 540?461?353 from
24R/S-hydroxycholesterol internal standard.
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completely dominated by GP-tagged 24S-hydroxycholesterol
(27.91 ± 0.73 ng/mg, mean ± SD, two mice were analysed in dupli-
cate preparations, Table 1) which, as a consequence of derivatisa-
tion, gives two peaks corresponding to the syn and anti
conformers of the GP-derivative. Trace levels of GP-tagged
(25R),26-hydroxycholesterol (approx. 0.3 ng/mg) are evident,
while low amounts of 25-, 7a- and 7b-hydroxycholesterol also
appear in some analysis (60.05 ng/mg). The identiﬁcation of oxys-
terols was conﬁrmed by comparison of accurate mass, retention
time and MSn spectra with those of authentic standards. As well
as the monohydroxycholesterol isomers, 24S,25-epoxycholesterol
was also found in brain of the wt animals. During the GP-tagging
reactions the 24S,25-epoxide isomerises to the 24-ketone, is
hydrolysed to the 24,25-diol and undergoes methanolysis to the
hydroxy-methoxide [21]. The level of ‘‘total’’ 24S,25-epoxycholes-
terol was determined to be 0.64 ± 0.02 ng/mg. Sterols with similar
polarity to cholesterol elute from the ﬁrst SPE column in fraction
SPE1-FR3. Analysis of this sterol fraction revealed a high level of
cholesterol (16 lg/mg) and a lower level of desmosterol (0.1 lg/
mg). Very low levels of the desmosterol precursor 7-dehydrodes-
mosterol were also observed (0.006 lg/mg).
3.2. Cyp46a1/ mice
In the Cyp46a1/ mouse deletion of the Cyp46a1 gene results
in a great reduction in the level of 24S-hydroxycholesterol in brain
(Table 1). This allows the injection of greater amounts of oxysterol
‘‘on-column’’ without the fear of column overloading, effectively
increasing the sensitivity of the analytical method from 50 pg/mg
to 5 pg/mg. Very low levels of 24S-hydroxycholesterol
(0.017 ± 0.003 ng/mg) were observed in brain of the Cyp46a1/
mouse as revealed in the RIC of m/z 534.4054 corresponding to
GP-tagged hydroxycholesterols (Fig. 2B) and by the MS3 spectrum
shown in Fig. 3B. In the absence of the Cyp46a1 enzyme it may be
expected that some other oxysterol would take on the role of the
‘‘cholesterol transporter’’ from brain to liver, however, in agree-ment with earlier studies [6] there was no matching increases in
the abundance of any other oxysterol. As in the wt mouse, low lev-
els of 25- and (25R),26-hydroxycholesterols (0.050 ± 0.009 ng/mL
and approx. 0.15 ng/mL, respectively) were evident in the Cy-
p46a1/ mice (Table 1). Surprisingly, the presence of a metabo-
lite eluting as two components just before, and just after,
(25R),26-hydroxycholesterol with retention times and MS3 spectra
corresponding to 24R-hydroxycholesterol (approx 0.15 ng/mg)
was observed (Figs. 2B and 3C). On account of the presence of a
fragment ion at m/z 353 in the MS3 spectra of both of the 24-
hydroxycholesterol isomers (Fig. 3A–C), but not the 25- or
(25R),26-hydroxycholesterol isomers (Fig. 3D), it is possible by
generating a multiple reaction monitoring (MRM) chromatogram
for the transitions 534?455?353 to ‘‘resolve’’ the 24-hydroxycho-
lesterol isomers from closely eluting 25- and (25R),26-hydroxy-
cholesterols as shown in Fig. 2C (the MS3 fragmentation of GP-
tagged 24-hydroxycholesterol is shown in Supplementary
Fig. S1). The fragment ion of m/z 353 is also observed in the MS3
spectrum of 24R/S-[2H6]hydroxycholesterol allowing the genera-
tion of a MRM chromatogram 540?461?353 (Fig. 2D). There were
also low levels of an additional side-chain hydroxylated oxysterol
(0.030 ± 0.035 ng/mg) eluting after the second peak of 24R-
hydroxycholesterol and before 7b-hydroxycholesterol. The MS3
spectrum suggested hydroxylation on a primary or secondary car-
bon of the side-chain. The ﬁnal eluting oxysterols from the RIC of
534.4054 are ring hydroxylated and correspond to 7b-, 7a- and
6-hydroxycholesterols. Very low levels of 22R-hydroxycholesterol
(<0.005 ng/mg, Fig. 2B), and 20R,22R-dihydroxycholesterol
(0.030 ± 0.002 ng/mg) were also evident in the Cyp46a1/ ani-
mals. As in the wt animal, 24S,25-epoxycholesterol was found in
brain from the Cyp46a1/ animal appearing as the GP-tagged
epoxide, its 24-oxo isomer and methanolysis and hydrolysis prod-
ucts (0.124 ± 0.044 ng/mg) .
Despite the absence of appreciable amounts of 24S-hydroxy-
cholesterol, or of a major replacement oxysterol in the brain of Cy-
p46a1/ mouse, the level of cholesterol was essentially identical
to that of the wild-type mouse (16 lg/mg). There was, however, a
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Fig. 3. MS3 (534?455?) spectra of monohydroxycholesterols in mouse brain. 24S-hydroxycholesterol from (A) Cyp46a1+/+, and (B) Cyp46a1/ mouse brain. (C) 24R-
Hydroxycholesterol and (D) (25R),26-hydroxycholesterol from Cyp46a1/ mouse brain.
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(0.06 lg/mg) compared to wt (0.1 lg/mg).4. Discussion
24S-Hydroxylation of cholesterol by Cyp46a1 accounts for
about two thirds of cholesterol turnover in mouse brain [22]. Sur-
prisingly, deletion of the Cyp46a1 gene in the cholesterol 24-
hydroxylase knockout mouse does not result in an increase in brain
cholesterol but rather a decrease in its rate of synthesis [6]. 24S-
Hydroxycholesterol is the dominant oxysterol in wt brain and its
high abundance tends to obscure the observation of other oxyster-
ols in brain. The current study, however, was designed to take
advantage of a reduction in brain 24S-hydroxycholesterol in the
Cyp46a1/ mouse to uncover other oxysterols that may provide
an alternative/additional export route for cholesterol from brain
or may have regulatory functions in brain.
In brain of the Cyp46a1/ mouse low levels of both 24S- and
24R-hydroxycholesterols were found (Table 1). It is not clear which
enzyme(s) generates these isomers and whether their synthesis oc-
curs in brain or if they are imported from the circulation. There are
few references to the presence of 24R-hydroxycholesterol in mam-
mals, although Spencer and colleagues have reported that this iso-
mer can be formed enzymatically from 24R,25-epoxycholesterolby Dede cells and by rat liver homogenate [23]. However,
24R,25-epoxycholesterol is not the natural 24,25-epoxide formed
via the shunt of the mevalonate pathway in mammals [24]. In
the brain of the Cyp46a1/ and also the wt mouse we ﬁnd low
levels of (25R),26-hydroxycholesterol (approx. 0.15 and 0.30 ng/
mL, respectively). Cyp27a1, the mitochondrial (25R),26-hydroxy-
lase, is known to be expressed in brain [25]. In brain of wt animals
the high level of 24S-hydroxycholesterol (27.91 ± 0.73 ng/mg) and
its close chromatographic elution to 25-hydroxycholesterol makes
the identiﬁcation of the latter oxysterol challenging. However, in
the absence of the Cyp46a1 gene the presence of 25-hydroxycho-
lesterol (0.050 ± 0.009 ng/mg) in brain is evident (Fig. 2B). 25-
Hydroxycholesterol has recently come to the attention of the lipid
community on account of its effects on the immune system
[26,27]. Studies show that it is produced and secreted by
macrophages in response to TLR activation [26,28]. Migroglia are
the resident macrophage of brain and spinal cord and it will be fas-
cinating to see if they show a similar response upon TLR activation.
The enzyme responsible for 7a-hydroxylation of cholesterol,
Cyp7a1, is liver speciﬁc [2], so the presence of 7a-hydroxycholes-
tertol in brain could be a consequence of diffusion of this oxysterol
across the blood brain barrier from the circulation. Both 7a- and
7b-hydroxycholesterols can be formed non-enzymatically from
cholesterol [29]. This may be as a result of oxidative stress [30],
or alternatively the oxysterols could be autoxidation artefacts
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the 5a and 5b isomers of 5,6-epoxycholesterol are formed from
cholesterol non-enzymatically [29]. 5,6-Epoxycholesterols are
hydrolysed enzymatically by a microsomal epoxide hydrolase to
cholestane-3b,5a,6b-triol. In our charge-tagging procedure 5,6-
epoxides undergo hydrolysis and then dehydration and are
detected as 6-hydroxycholesterol. In the current study with the Cy-
p46a1/ mouse we also observe both 22R-hydroxycholesterol
and 20R,22R-dihydroxycholesterol in the brain. Cyp11a1 is the en-
zyme which converts cholesterol into these metabolites.
Oxysterols are in their own right biologically active molecules
as ligands to Lxr [11,12], as inhibitors of the processing of SREBPs
to their active forms as transcription factors [9], and as modulators
of the immune response [26]. Recent studies have shown that Lxr
signalling is important for the development of dopaminergic
neurons through 24S,25-epoxycholesterol [14]. 24S,25-Epoxycho-
lesterol is present in brain in both the wt and Cyp46a1/ animals,
however, the level in the knockout animal is considerably lower
than in the wt. This is not surprising as 24S,25-epoxycholesterol
is produced in a shunt of the mevalonate pathway by the identical
enzymes as cholesterol, and the rate of cholesterol synthesis is
reduced in the knockout mouse. Interestingly, symptoms of Parkin-
son’s disease, the phenotype of dopaminergic neuron loss, have not
been observed to-date in the Cyp46a1/ mouse. The reduced le-
vel of desmosterol in the brain of the Cyp46a1/ animal is also in
agreement with a reduced rate of cholesterol synthesis. Interest-
ingly desmosterol has also been shown to be an Lxr ligand [32,33].
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